BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation Study.

Autor: Louw A; Department of Anatomical Pathology, PathWest Laboratory Medicine, QEII Medical Centre, Perth, Australia; School of Medical and Health Sciences, Edith Cowan University, Perth, Australia; Institute for Respiratory Health, Perth, Australia; National Centre for Asbestos Related Disease, University of Western Australia, Perth, Australia., Panou V; Department of Respiratory Medicine, Odense University Hospital, Odense, Denmark; Department of Respiratory Diseases, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Szejniuk WM; Department of Oncology & Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University Hospital, Aalborg, Denmark., Meristoudis C; Institute of Pathology, Aalborg University Hospital, Aalborg, Denmark., Chai SM; Department of Anatomical Pathology, PathWest Laboratory Medicine, QEII Medical Centre, Perth, Australia., van Vliet C; Department of Anatomical Pathology, PathWest Laboratory Medicine, QEII Medical Centre, Perth, Australia., Lee YCG; Institute for Respiratory Health, Perth, Australia; Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, Australia; Medical School, University of Western Australia, Perth, Australia., Dick IM; National Centre for Asbestos Related Disease, University of Western Australia, Perth, Australia., Firth T; Institute for Respiratory Health, Perth, Australia; National Centre for Asbestos Related Disease, University of Western Australia, Perth, Australia., Lynggaard LA; Institute of Pathology, Aalborg University Hospital, Aalborg, Denmark., Asghari AB; Institute of Pathology, Aalborg University Hospital, Aalborg, Denmark., Vyberg M; Center for RNA Medicine, Department of Clinical Medicine, Aalborg University, Copenhagen, Denmark., Hansen J; Danish Cancer Society, Research Center, Copenhagen, Denmark., Creaney J; Institute for Respiratory Health, Perth, Australia; National Centre for Asbestos Related Disease, University of Western Australia, Perth, Australia; Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, Australia. Electronic address: jenette.creaney@uwa.edu.au., Røe OD; Department of Oncology & Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University Hospital, Aalborg, Denmark; Department of Oncology, Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, Norway; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2022 Jul; Vol. 17 (7), pp. 921-930. Date of Electronic Publication: 2022 Apr 27.